ResMed Inc. (RMD Quick QuoteRMD - Free Report) was a big mover last session, as the company saw its shares rise more than 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $84.69 to $88.19 in the past one month time frame.

The move came after the company reported better-than-expected second-quarter fiscal 2018 results.

The company has not seen any estimate revisions in the past month, while the Zacks Consensus Estimate has moved higher over the said time period, suggesting that more solid trading could be ahead for ResMed. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

ResMed currently has a Zacks Rank #2 (Buy), while its Earnings ESP is positive.

Investors interested in the Medical - Products industry may consider Bio-Rad Laboratories, Inc. (BIO Quick QuoteBIO - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is RMD going up? Or down? Predict to see what others think: Up or Down

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>